GLP-1 drugs , or glucagon-like peptide-1 compounds, represent a truly shift in how we approach type 2 diabetes . These injectable therapies help imitating the body’s inherent GLP-1 process, which https://jimwecd901034.jaiblogs.com/69044226/glp-1-a-significant-advance-in-glucose-management